InsidersTradesSigma
Track the Gabather AB stock price and the full management transaction log of the company, a publicly traded company based in Finland. Shares are listed on the FI market, under the supervision of FIN-FSA. Operating in the Health Care sector, Gabather AB has published 1 public disclosures. Market capitalisation: €18.8m. The latest transaction was reported on 2 December 2025 (Other). Among the most active insiders: Michael Witt. All data is openly available.
1
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
37Σ signal
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 2 December 2025
Declarations1 total
8,562,330 shares@ €0.00230.094% mcap100.0% of flowAktieISIN SE0010869552FI:A003U294-2
1 of 1 declaration
About Gabather AB
Gabather AB is a Swedish pharmaceutical company focused on developing treatments for neurological disorders. It is listed on the Stockholm Stock Exchange (XSTO).